We read with interest the review article by Park et al. “The ketogenic diet for super-refractory
status epilepticus patients in intensive care units” published online in the Brain
& Development [
[1]
]. The authors retrospectively reviewed the medical records of 16 children with super-refractory
status epilepticus (SRSE), who were treated with the ketogenic diet (KD) in the intensive
care unit of the hospital. The authors concluded that their experience indicates that
the KD is an effective alternative therapeutic strategy for SRSE patients in ICUs
with adequate efficacy and safety in reducing seizure frequency. Although we agree
with most of the authors’ experience we would like to put one question.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Brain and DevelopmentAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The ketogenic diet for super-refractory status epilepticus patients in intensive care units.Brain Dev. 2019; (pii: S0387-7604(18)30173-6)
- Complications during ketogenic diet initiation: prevalence, treatment, and influence on seizure outcomes.Pediatr Neurol. 2017; 68: 35-39
- A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus.Neurocrit Care. 2017; 26: 267-272
Article info
Publication history
Published online: February 22, 2019
Accepted:
February 12,
2019
Received:
February 4,
2019
Identification
Copyright
© 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
